Kronos' dividend cut and persistent negative free cash flow highlight ongoing financial strain, with no clear catalysts for improvement on the horizon. Dividend yield is now just 2.99%, lagging ...

Kronos’ most advanced drug candidate was istisociclib, which was discontinued in November 2024. The drug was in Phase II development for treatment-resistant ovarian cancer. Preclinical drugs on the ...

The deal is somewhat of a saving grace for struggling Kronos. A few weeks ago, the small-molecule-focused biotech closed its headquarters in California in an attempt to save money.

(RTTNews) - Kronos Bio (KRON) has entered into a definitive merger agreement with Concentra Biosciences, LLC, whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio ...

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers ...

Kronos Quartet Performed Friday at Zankel Hall A version of this article appears in print on , Section C, Page 5 of the New York edition with the headline: New Faces Refresh A Venerable Group.

NAMM 2025: Korg has revived its beloved Kronos workstation, unveiling an updated model that promises to be faster and more flexible then previous incarnations, as well as being packed with fresh ...

Kronos also excels at using Minor God abilities, which are some of the strongest in the game. Kronos' first age Deconstruction ability can be used to immediately destroy one enemy building and can ...

Then you get heroes, which are, admittedly, a lot like Age of Empires’ heroes, but with flashier, god-given powers, and a selection of units unique to whatever civilization you chose – high ...